Proposed Merger with GSS not proceeding
Released
Released
Announcement PDF
ASX Announcement
18 November 2026
JOIN MICROBA’S INTERACTIVE INVESTOR HUB
For more Company information and to engage with management by asking questions about Microba’s latest announcements
and updates, visit ir.microba.com/welcome
Microba Life Sciences Ltd | ABN 82 617 096 652 | L10, 324 Queen Street, Brisbane QLD 4000 Australia | 1300 974 621
Proposed Merger with Genetic Signatures Limited not
proceeding
Microba Life Sciences Limited (ASX: MAP) (“Microba” or “the Company”) refers to previous announcements
relating to the proposed merger between Genetic Signatures Limited (ASX: GSS) (GSS) and Microba (Proposed
Merger) as well as Microba’s request for a voluntary suspension of trading in its securities on 17 November 2026
while it explores funding options.
Unfortunately, as announced by GSS today, GSS has resolved not to proceed with the Proposed Merger in light
of Microba’s announcement that it will not have financial capacity to complete the Proposed Merger without
additional capital. The Proposed Merger will therefore not proceed.
The requirement for additional capital was a result of Tranche 2 of Microba's institutional placement, announced to
the ASX on 20 October 2026 (Placement) not being able to proceed on the basis that revisions to the indicative
terms of the Proposed Merger, while considered generally commercially acceptable to the Microba Board, were
such that Microba could not satisfy the conditions to the Placement.
This is a disappointing outcome as it follows many months of discussions, engagement and due diligence and
Microba had been working on options to obtain alternative funding.
Notwithstanding that the Proposed Merger is not progressing, Microba is continuing to assess its cashflow
position and is exploring its options for funding whilst it remains in voluntary suspension.
This announcement has been authorised for release by the Board of Directors.
About Microba Life Sciences Limited
Microba is at the forefront of microbiome health and human care. With world-leading science, insights and
collaboration tools, Microba's vision is to deliver clinical-grade microbiome tests that help people live healthier,
happier lives. Better science. Better insights. Better health. Microba - Expect better. www.microba.com
Share your feedback
Discover